• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在墨西哥独特且高度基因混合的宿主群体中,HIV上较弱的HLA印记。

Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.

作者信息

Soto-Nava Maribel, Avila-Ríos Santiago, Valenzuela-Ponce Humberto, García-Morales Claudia, Carlson Jonathan M, Tapia-Trejo Daniela, Garrido-Rodriguez Daniela, Alva-Hernández Selma N, García-Tellez Thalía A, Murakami-Ogasawara Akio, Mallal Simon A, John Mina, Brockman Mark A, Brumme Chanson J, Brumme Zabrina L, Reyes-Teran Gustavo

机构信息

Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.

Microsoft Research, Redmond, Washington, USA.

出版信息

J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01128-17. Print 2018 Jan 15.

DOI:10.1128/JVI.01128-17
PMID:29093100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752930/
Abstract

HIV circumvents HLA class I-restricted CD8 T-cell responses through selection of escape mutations that leave characteristic mutational "footprints," also known as HLA-associated polymorphisms (HAPs), on HIV sequences at the population level. While many HLA footprints are universal across HIV subtypes and human populations, others can be region specific as a result of the unique immunogenetic background of each host population. Using a published probabilistic phylogenetically informed model, we compared HAPs in HIV Gag and Pol (PR-RT) in 1,612 subtype B-infected, antiretroviral treatment-naive individuals from Mexico and 1,641 individuals from Canada/United States. A total of 252 HLA class I allele subtypes were represented, including 140 observed in both cohorts, 67 unique to Mexico, and 45 unique to Canada/United States. At the predefined statistical threshold of a q value of <0.2, 358 HAPs (201 in Gag, 157 in PR-RT) were identified in Mexico, while 905 (534 in Gag and 371 in PR-RT) were identified in Canada/United States. HAPs identified in Mexico included both canonical HLA-associated escape pathways and novel associations, in particular with HLA alleles enriched in Amerindian and mestizo populations. Remarkably, HLA footprints on HIV in Mexico were not only fewer but also, on average, significantly weaker than those in Canada/United States, although some exceptions were noted. Moreover, exploratory analyses suggested that the weaker HLA footprint on HIV in Mexico may be due, at least in part, to weaker and/or less reproducible HLA-mediated immune pressures on HIV in this population. The implications of these differences for natural and vaccine-induced anti-HIV immunity merit further investigation. HLA footprints on HIV identify viral regions under intense and consistent pressure by HLA-restricted immune responses and the common mutational pathways that HIV uses to evade them. In particular, HLA footprints can identify novel immunogenic regions and/or epitopes targeted by understudied HLA alleles; moreover, comparative analyses across immunogenetically distinct populations can illuminate the extent to which HIV immunogenic regions and escape pathways are shared versus population-specific pathways, information which can in turn inform the design of universal or geographically tailored HIV vaccines. We compared HLA-associated footprints on HIV in two immunogenetically distinct North American populations, those of Mexico and Canada/United States. We identify both shared and population-specific pathways of HIV adaptation but also make the surprising observation that HLA footprints on HIV in Mexico overall are fewer and weaker than those in Canada/United States, raising the possibility that HLA-restricted antiviral immune responses in Mexico are weaker, and/or escape pathways somewhat less consistent, than those in other populations.

摘要

人类免疫缺陷病毒(HIV)通过选择逃逸突变来规避HLA I类分子限制的CD8 T细胞反应,这些逃逸突变在群体水平的HIV序列上留下特征性的突变“足迹”,也称为HLA相关多态性(HAPs)。虽然许多HLA足迹在HIV各亚型和人类群体中是普遍存在的,但由于每个宿主群体独特的免疫遗传背景,其他一些足迹可能具有区域特异性。我们使用一个已发表的基于概率系统发育的模型,比较了来自墨西哥的1612名未接受抗逆转录病毒治疗的B亚型感染个体和来自加拿大/美国的1641名个体中HIV Gag和Pol(蛋白酶-逆转录酶,PR-RT)基因中的HAPs。总共涵盖了252种HLA I类等位基因亚型,其中140种在两个队列中均有观察到,67种是墨西哥特有的,45种是加拿大/美国特有的。在预先设定的统计阈值q值<0.2时,在墨西哥鉴定出358个HAPs(Gag基因中有201个,PR-RT基因中有157个),而在加拿大/美国鉴定出905个(Gag基因中有534个,PR-RT基因中有371个)。在墨西哥鉴定出的HAPs既包括经典的HLA相关逃逸途径,也包括新的关联,特别是与在美洲印第安人和混血人群中富集的HLA等位基因的关联。值得注意的是,墨西哥HIV上的HLA足迹不仅数量较少,而且平均而言明显弱于加拿大/美国的,尽管也有一些例外情况。此外,探索性分析表明,墨西哥HIV上较弱的HLA足迹可能至少部分是由于该人群中HLA介导的对HIV的免疫压力较弱和/或重复性较差。这些差异对天然和疫苗诱导的抗HIV免疫的影响值得进一步研究。HIV上的HLA足迹可识别受到HLA限制的免疫反应强烈且持续压力的病毒区域,以及HIV用来逃避这些压力的常见突变途径。特别是,HLA足迹可以识别未充分研究的HLA等位基因靶向的新免疫原性区域和/或表位;此外,对免疫遗传不同人群的比较分析可以阐明HIV免疫原性区域和逃逸途径在多大程度上是共享的,以及哪些是特定人群的途径,这些信息反过来又可为通用或针对特定地理区域的HIV疫苗设计提供参考。我们比较了墨西哥和加拿大/美国这两个免疫遗传不同的北美人群中HIV上与HLA相关的足迹。我们确定了HIV适应的共享途径和特定人群途径,但也令人惊讶地观察到,墨西哥HIV上的HLA足迹总体上比加拿大/美国的更少、更弱,这增加了墨西哥HLA限制的抗病毒免疫反应比其他人群更弱和/或逃逸途径不太一致的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/25e7f5770e0f/zjv0021832440009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/e3b4f2e99a14/zjv0021832440001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/b7c4ce84988c/zjv0021832440002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/3e0ed9a63eb8/zjv0021832440003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/4779bac0d208/zjv002183244004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/c3ff42761981/zjv002183244005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/43038008b3f4/zjv0021832440006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/b35e564cd456/zjv0021832440007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/1e3002812b76/zjv0021832440008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/25e7f5770e0f/zjv0021832440009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/e3b4f2e99a14/zjv0021832440001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/b7c4ce84988c/zjv0021832440002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/3e0ed9a63eb8/zjv0021832440003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/4779bac0d208/zjv002183244004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/c3ff42761981/zjv002183244005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/43038008b3f4/zjv0021832440006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/b35e564cd456/zjv0021832440007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/1e3002812b76/zjv0021832440008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73f/5752930/25e7f5770e0f/zjv0021832440009.jpg

相似文献

1
Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.在墨西哥独特且高度基因混合的宿主群体中,HIV上较弱的HLA印记。
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01128-17. Print 2018 Jan 15.
2
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.聚合酶驱动的复制能力影响 HIV-1 型 C 亚型感染的疾病进展。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00811-18. Print 2018 Oct 1.
3
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.基因和机制解析 HIV 对宿主细胞免疫的适应性的亚型特异性
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01502-18. Print 2019 Jan 1.
4
Host-specific adaptation of HIV-1 subtype B in the Japanese population.日本人群中 HIV-1 亚型 B 的宿主特异性适应。
J Virol. 2014 May;88(9):4764-75. doi: 10.1128/JVI.00147-14. Epub 2014 Feb 12.
5
Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study.墨西哥队列中HLA介导的HIV进化的独特特征:一项比较研究。
Retrovirology. 2009 Aug 10;6:72. doi: 10.1186/1742-4690-6-72.
6
Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.在未经治疗的日本个体中,Gag蛋白酶介导的HIV-1复制能力对临床参数缺乏显著影响。
Retrovirology. 2015 Nov 19;12:98. doi: 10.1186/s12977-015-0223-z.
7
Widespread impact of HLA restriction on immune control and escape pathways of HIV-1.HLA 限制对 HIV-1 免疫控制和逃逸途径的广泛影响。
J Virol. 2012 May;86(9):5230-43. doi: 10.1128/JVI.06728-11. Epub 2012 Feb 29.
8
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.HIV-1功能基因和辅助/调节基因中HLA I类分子介导的病毒差异进化的证据。
PLoS Pathog. 2007 Jul;3(7):e94. doi: 10.1371/journal.ppat.0030094.
9
APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.APOBEC3G 对适应性免疫与病毒免疫逃逸之间进化竞争的调控在 HIV 基因组中留下了深刻的印记。
Front Immunol. 2019 Jan 11;9:3032. doi: 10.3389/fimmu.2018.03032. eCollection 2018.
10
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.在群体水平上,HIV-1适应HLA限制的免疫反应的证据。
Science. 2002 May 24;296(5572):1439-43. doi: 10.1126/science.1069660.

引用本文的文献

1
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release.IL-2 装甲肽-主要组织相容性复合体 I 双特异性抗体将抗病毒效应记忆 CD8+T 细胞重定向,以诱导具有有限细胞因子释放的强大抗肿瘤细胞毒性活性。
MAbs. 2024 Jan-Dec;16(1):2395499. doi: 10.1080/19420862.2024.2395499. Epub 2024 Aug 28.
2
Changing selection on amino acid substitutions in Gag protein between major HIV-1 subtypes.主要HIV-1亚型之间Gag蛋白氨基酸替换的选择变化
Virus Evol. 2024 May 4;10(1):veae036. doi: 10.1093/ve/veae036. eCollection 2024.
3

本文引用的文献

1
Identification of major routes of HIV transmission throughout Mesoamerica.中美洲地区艾滋病毒主要传播途径的识别。
Infect Genet Evol. 2017 Oct;54:98-107. doi: 10.1016/j.meegid.2017.06.021. Epub 2017 Jun 20.
2
Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.由HLA - B*52:01 - C*12:02保护性单倍型限制的细胞毒性T淋巴细胞选择的Pol突变的积累,由于突变病毒的低病毒适应性导致血浆病毒载量低。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.02082-16. Print 2017 Feb 15.
3
Impact of pre-adapted HIV transmission.
Unveiling ecological/evolutionary insights in HIV viral load dynamics: Allowing random slopes to observe correlational changes to CpG-contents and other molecular and clinical predictors.
揭示 HIV 病毒载量动态中的生态/进化见解:允许随机斜率观察与 CpG 含量及其他分子和临床预测因子的相关性变化。
Epidemics. 2024 Jun;47:100770. doi: 10.1016/j.epidem.2024.100770. Epub 2024 May 14.
4
Rapid Near Point-of-Care Assay for Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.用于阿巴卡韦严重过敏反应相关基因型的快速即时检测方法。
AIDS Res Hum Retroviruses. 2021 Dec;37(12):930-935. doi: 10.1089/AID.2021.0103. Epub 2021 Nov 30.
5
Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.HIV 对 HLA 的适应的临床和进化后果:对疫苗和治愈的影响。
Curr Opin HIV AIDS. 2019 May;14(3):194-204. doi: 10.1097/COH.0000000000000541.
6
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.基因和机制解析 HIV 对宿主细胞免疫的适应性的亚型特异性
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01502-18. Print 2019 Jan 1.
7
Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.新型 HLA Ⅰ类等位基因与独特遗传混合人群中 HIV-1 控制的关联。
Sci Rep. 2018 Apr 17;8(1):6111. doi: 10.1038/s41598-018-23849-7.
预适应的HIV传播的影响。
Nat Med. 2016 Jun;22(6):606-13. doi: 10.1038/nm.4100. Epub 2016 May 16.
4
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.MEGA7:适用于更大数据集的分子进化遗传学分析版本7.0
Mol Biol Evol. 2016 Jul;33(7):1870-4. doi: 10.1093/molbev/msw054. Epub 2016 Mar 22.
5
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.具有高全球HIV-1覆盖率的新型保守区域T细胞镶嵌疫苗在未经治疗的感染中被保护性反应识别。
Mol Ther. 2016 Apr;24(4):832-42. doi: 10.1038/mt.2016.3. Epub 2016 Jan 8.
6
HIV-specific CD8⁺ T cells and HIV eradication.HIV特异性CD8⁺ T细胞与HIV根除
J Clin Invest. 2016 Feb;126(2):455-63. doi: 10.1172/JCI80566. Epub 2016 Jan 5.
7
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.保守镶嵌疫苗的价数增加可增强表位识别的广度和深度。
Mol Ther. 2016 Feb;24(2):375-384. doi: 10.1038/mt.2015.210. Epub 2015 Nov 19.
8
Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.北美疫情期间HIV-1聚合酶的群体水平免疫介导适应性
J Virol. 2015 Nov 11;90(3):1244-58. doi: 10.1128/JVI.02353-15. Print 2016 Feb 1.
9
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.HLA-B*13相关逃逸突变对HIV-1复制及Nef功能的影响
J Virol. 2015 Nov;89(22):11557-71. doi: 10.1128/JVI.01955-15. Epub 2015 Sep 9.
10
HIV-1 adaptation to HLA: a window into virus-host immune interactions.HIV-1 对 HLA 的适应:揭示病毒-宿主免疫相互作用的窗口。
Trends Microbiol. 2015 Apr;23(4):212-24. doi: 10.1016/j.tim.2014.12.008. Epub 2015 Jan 19.